Oncology Practice Group Leaves Allegheny For Former Rival UPCI; Will NSABP Follow?
Cornell, MSKCC, Rockefeller To collaborate In $160M Basic Biological Research Program.
North General, MSK, Form Cancer Prevention Center.
Human Genome Consortium Completes “Working Draft”.
NCI Plans $40M In Grants For Cancer Outcomes Studies.
Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.
FDA Approves Large-Volume Processor For Cytyc’s ThinPrep Pap Test Samples.
Sustained-Release Leuprolide Under Study In Phase III Trial.
Celgene Signs CRADA With NCI For Development Of CDC-501.
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
- John Burklow replaced by Seana Cranston as NIH chief of staff









